Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

OBJECTIVES: To compare responses in patients with early rheumatoid arthritis (RA) initially treated with the tumour necrosis factor inhibitor (TNFi) adalimumab+methotrexate (MTX) versus MTX monotherapy who may have continued receiving MTX or switched to adalimumab rescue therapy after inadequate res...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Kavanaugh, Arthur, van Vollenhoven, Ronald F, Fleischmann, Roy, Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Chen, Su, Guérette, Benoît, Kupper, Hartmut, Smolen, Josef S
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5867415/
https://ncbi.nlm.nih.gov/pubmed/29146743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2017-211871
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados